Patents by Inventor Christopher Lindsay
Christopher Lindsay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11920177Abstract: The biological production of beta-hydroxyisovalerate (?HIV) using a non-natural microorganism. The non-natural microorganism for the biologically-derived ?HIV provides more beta-hydroxyisovalerate synthase activity than the wild-type parent. The non-natural microorganism can host a non-natural enzyme, such as the non-natural enzyme expressed in a yeast or bacteria, wherein the non-natural microorganism comprises an active ?HIV metabolic pathway for the production of ?HIV. The biological derivation of ?HIV eliminates toxic by-products and impurities that result from the chemical production of ?HIV, such that ?HIV produced by a non-natural microorganism prior to any isolation or purification process has not been in substantial contact with any halogen-containing component.Type: GrantFiled: April 6, 2022Date of Patent: March 5, 2024Assignee: SASYA INC.Inventors: Goutham Vemuri, Christopher Lindsay, Kevin Roberg-Perez, Christopher D. Snow, Elizabeth A. Cameron
-
Publication number: 20230263943Abstract: Compositions and methods are provided for lamellar and defect reconstruction of corneal stromal tissue using biomaterials that form a defined hydrogel structure in situ, including interpenetrating (IPN) and semi-IPN hydrogels.Type: ApplicationFiled: April 29, 2021Publication date: August 24, 2023Inventors: David Myung, Fang Chen, Gabriella Fernandes-Cunha, Sarah Hull, Sarah Heilshorn, Christopher Lindsay, Christopher Madl, Hyun Jong Lee
-
Publication number: 20220325304Abstract: The biological production of beta-hydroxyisovalerate (?HIV) using at least one non-natural enzyme. The non-natural enzyme for the biologically-derived ?HIV provides more beta-hydroxyisovalerate synthase activity than the wild-type parent. The non-natural enzyme having one or more modifications of substrate-specificity positions. The non-natural enzyme can be expressed in a microorganism, such as a yeast or bacteria, wherein the microorganism comprises an active ?HIV metabolic pathway for the production of ?HIV. Alternatively, the non-natural enzyme can be a ?HIV synthase used to produce ?HIV in a cell-free environment. The biological derivation of ?HIV eliminates toxic by-products and impurities that result from the chemical production of ?HIV, such that ?HIV produced by a non-natural enzyme prior to any isolation or purification process has not been in substantial contact with any halogen-containing component.Type: ApplicationFiled: April 6, 2022Publication date: October 13, 2022Inventors: Goutham Vemuri, Christopher Lindsay, Kevin Roberg-Perez, Christopher D. Snow, Elizabeth A. Cameron
-
Publication number: 20220315954Abstract: The biological production of beta-hydroxyisovalerate (?HIV) using a non-natural microorganism. The non-natural microorganism for the biologically-derived ?HIV provides more beta-hydroxyisovalerate synthase activity than the wild-type parent. The non-natural microorganism can host a non-natural enzyme, such as the non-natural enzyme expressed in a yeast or bacteria, wherein the non-natural microorganism comprises an active ?HIV metabolic pathway for the production of ?HIV. The biological derivation of ?HIV eliminates toxic by-products and impurities that result from the chemical production of ?HIV, such that ?HIV produced by a non-natural microorganism prior to any isolation or purification process has not been in substantial contact with any halogen-containing component.Type: ApplicationFiled: April 6, 2022Publication date: October 6, 2022Inventors: Goutham Vemuri, Christopher Lindsay, Kevin Roberg-Perez, Christopher D. Snow, Elizabeth A. Cameron
-
Publication number: 20210244659Abstract: Compositions and methods are provided for lamellar and defect reconstruction of corneal stromal tissue using biomaterials that form a defined gel structure in situ. Such gels can serve as cellular or acellular lamellar substitutes to reconstruct corneal stroma, facilitate matrix remodeling, and support multilayered re-epithelialization of wounded corneal stromal tissue, as well delivery vehicles for cells, biomolecules, and/or pharmaceutical agents to wound sites throughout the body.Type: ApplicationFiled: June 27, 2019Publication date: August 12, 2021Inventors: David Myung, Sarah Hull, Sarah Heilshorn, Christopher Lindsay, Christopher Madl, Hyun Jong Lee
-
Patent number: 10883808Abstract: A munition includes a munition body containing explosive material. An electronic subsystem is active between release and detonation of the explosive material. One or more batteries are electrically connected to the electronic subsystem to provide power to the electronic subsystem prior to detonation. The one or more batteries are positioned adjacent to the explosive material to be accelerated outward as corresponding munition projectiles after detonation, increasing the effective payload of the munition by performing dual functions. In one or more embodiments, the explosive material is cylindrically shaped and longitudinally aligned in a warhead section of the munition body. The one or more batteries are annularly positioned on lateral surface of the explosive surface to form a cellular fragmenting structure. In a particular embodiments, the munition body is a missile body containing a rocket propulsion system and the electronic subsystem comprises a missile guidance system.Type: GrantFiled: December 3, 2019Date of Patent: January 5, 2021Assignee: United States of America as represented by the Secretary of the Air ForceInventors: Geremy Kleiser, Christopher Crouse, Christopher Lindsay, Ian Kowalczyk, Walter McCracken, Alan Yeates
-
Publication number: 20200248996Abstract: A munition includes a munition body containing explosive material. An electronic subsystem is active between release and detonation of the explosive material. One or more batteries are electrically connected to the electronic subsystem to provide power to the electronic subsystem prior to detonation. The one or more batteries are positioned adjacent to the explosive material to be accelerated outward as corresponding munition projectiles after detonation, increasing the effective payload of the munition by performing dual functions. In one or more embodiments, the explosive material is cylindrically shaped and longitudinally aligned in a warhead section of the munition body. The one or more batteries are annularly positioned on lateral surface of the explosive surface to form a cellular fragmenting structure. In a particular embodiments, the munition body is a missile body containing a rocket propulsion system and the electronic subsystem comprises a missile guidance system.Type: ApplicationFiled: December 3, 2019Publication date: August 6, 2020Inventors: Geremy Kleiser, Christopher Crouse, Christopher Lindsay, Ian Kowalczyk, Walter McCracken, Alan Yeates, Robert Tompkins
-
Patent number: 9832152Abstract: Exemplary methods, apparatuses, and systems receive an instruction to establish a rule to take an action on each email message received from a first email address, determine that the first email address is associated with contact data, determine that the contact data is associated with a second email address, and apply the rule to take the action on each email message received from the second email address.Type: GrantFiled: October 14, 2014Date of Patent: November 28, 2017Assignee: Apple Inc.Inventors: Scott Forstall, Terry Blanchard, Daniel Shteremberg, Angela Guzman, Stephen Lemay, Phillip Tao, Christopher Lindsay, Ashley Clark
-
Publication number: 20120210298Abstract: Tools are provided for locating changes in source code. More particularly, tools are provided for use with an integrated development environment having a source code management system for locating related changes in source code. Changed elements of target source code are located in a source code repository by acquiring a search term and by locating one or more references to changed elements of target source code containing the search term, wherein the located references are provided in order of the most recently changed located source code reference.Type: ApplicationFiled: February 9, 2012Publication date: August 16, 2012Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventors: Christopher Lindsay Hodgins, Daniel Lisle
-
Publication number: 20070149751Abstract: A polymer having the following general formula: where, PU is a polymer chain comprising at least one polyurethane chain; n ranges from 0 to 8; and X, Y and Z, identical or different, are H-bonding sites. Also provided is a supramolecular polymer comprising units that form H-bonds with one another, wherein at least one of these units is a polymer according to the invention. The supramolecular polymer is useful as a hot melt adhesive, in rotational or slush molding, in injection molding, and in the manufacture of thermoplastic polyurethane foams. Further provided is a process for the preparation of the polymer on bench and commercial scales.Type: ApplicationFiled: December 14, 2006Publication date: June 28, 2007Inventors: Christopher Lindsay, Steve Woutters
-
Publication number: 20060042981Abstract: A tape holding device that holds and protects a microcassette. The tape holding device includes a pair of opposing rails, a stop tab and a retention button for securing the microcassette to the device. The device further includes a pair of upper holes through which a clip can be inserted to secure the tape holding device to a file folder. The tape holding device also includes side holes that allow the device to be inserted onto two rings of a three-ring binder. The tape holding device further includes a groove that allows the device to be flexed up and provides a recess for accepting a binder clip. The tape holding device also includes retention flights so that allow a rubber band to secure the device to a file folder. The tape holding device further includes a message area.Type: ApplicationFiled: September 2, 2004Publication date: March 2, 2006Applicant: Caddy Industries, L.L.C.Inventors: Christopher Lindsay, Mark Rathbone
-
Patent number: D490828Type: GrantFiled: February 7, 2003Date of Patent: June 1, 2004Assignee: Roslin Manufacturing, LLCInventors: David Christopher Lindsay, Fernando Luis Rosales